rs116138787

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001278689.2(EOGT):​c.563A>T​(p.Lys188Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00169 in 1,614,114 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K188L) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0084 ( 19 hom., cov: 31)
Exomes 𝑓: 0.00099 ( 21 hom. )

Consequence

EOGT
NM_001278689.2 missense

Scores

2
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.13

Publications

1 publications found
Variant links:
Genes affected
EOGT (HGNC:28526): (EGF domain specific O-linked N-acetylglucosamine transferase) This gene encodes an enzyme that acts in the lumen of the endoplasmic reticulum to catalyze the transfer of N-acetylglucosamine to serine or threonine residues of extracellular-targeted proteins. This enzyme modifies proteins containing eukaryotic growth factor (EGF)-like domains, including the Notch receptor, thereby regulating developmental signalling. Mutations in this gene have been observed in individuals with Adams-Oliver syndrome 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
EOGT Gene-Disease associations (from GenCC):
  • Adams-Oliver syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Adams-Oliver syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00980404).
BP6
Variant 3-69004435-T-A is Benign according to our data. Variant chr3-69004435-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 445295.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00835 (1272/152296) while in subpopulation AFR AF = 0.0284 (1182/41564). AF 95% confidence interval is 0.0271. There are 19 homozygotes in GnomAd4. There are 614 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EOGTNM_001278689.2 linkc.563A>T p.Lys188Ile missense_variant Exon 8 of 18 ENST00000383701.8 NP_001265618.1 Q5NDL2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EOGTENST00000383701.8 linkc.563A>T p.Lys188Ile missense_variant Exon 8 of 18 1 NM_001278689.2 ENSP00000373206.3 Q5NDL2-1

Frequencies

GnomAD3 genomes
AF:
0.00836
AC:
1272
AN:
152178
Hom.:
19
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0285
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00353
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00230
AC:
578
AN:
251450
AF XY:
0.00180
show subpopulations
Gnomad AFR exome
AF:
0.0278
Gnomad AMR exome
AF:
0.00162
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.000814
GnomAD4 exome
AF:
0.000991
AC:
1448
AN:
1461818
Hom.:
21
Cov.:
30
AF XY:
0.000949
AC XY:
690
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.0299
AC:
999
AN:
33458
American (AMR)
AF:
0.00195
AC:
87
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00161
AC:
139
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5766
European-Non Finnish (NFE)
AF:
0.000109
AC:
121
AN:
1111970
Other (OTH)
AF:
0.00151
AC:
91
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
70
139
209
278
348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00835
AC:
1272
AN:
152296
Hom.:
19
Cov.:
31
AF XY:
0.00824
AC XY:
614
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0284
AC:
1182
AN:
41564
American (AMR)
AF:
0.00353
AC:
54
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00270
AC:
13
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68030
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
59
118
177
236
295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00144
Hom.:
0
Bravo
AF:
0.00955
ESP6500AA
AF:
0.0225
AC:
99
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00273
AC:
331
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 27, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 18, 2024
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
18
DANN
Benign
0.88
DEOGEN2
Benign
0.11
T;.;T;.
Eigen
Benign
-0.99
Eigen_PC
Benign
-0.90
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.70
.;.;T;T
MetaRNN
Benign
0.0098
T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.3
L;L;L;L
PhyloP100
1.1
PrimateAI
Benign
0.27
T
PROVEAN
Uncertain
-4.2
D;D;.;.
REVEL
Benign
0.080
Sift
Benign
0.057
T;T;.;.
Sift4G
Benign
0.14
T;T;T;T
Polyphen
0.0010
B;B;B;B
Vest4
0.41
MVP
0.19
MPC
0.26
ClinPred
0.046
T
GERP RS
-1.8
Varity_R
0.075
gMVP
0.63
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116138787; hg19: chr3-69053586; API